Med Ad News spoke with digital guru Fabio Gratton about the present and future of augmented and virtual reality technologies in pharma and healthcare.
The healthcare ad industry continues to thrive and adapt to the new demands for relevance and creativity.
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
The Medical Advertising Hall of Fame honored 2019 inductees Carol DiSanto and Charlene Prounis on Feb. 7th at The Pierre in New York City.
The threatened “pharma marketing tax” may be back in play during 2019, at both the federal and state levels.
The U.S. Department of Health and Human Services (HHS) is considering proposing a plan that has many moving parts, one of which could potentially take the price that Medicare pays out to providers for Medicare Part B drugs and turn it on its head.
The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.
For the tenth year, Med Ad News chose new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
GSW, an INC Research/inVentiv Health company and industry leader in healthcare advertising, named Sonja Foster-Storch as president. Foster-Storch reports to Lisa Stockman, president of inVentiv Health Communications.
Two Omnicom Health Group agencies will have new leadership as of January 1, 2018. Mario Muredda was named CEO of Harrison and Star, and Kristin Kantak will be CEO of Biolumina.
The Inception Companies appointed Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units.
AR/VR Special Feature 2019 – Game changer: The role of immersive technologies in the healthcare and pharmaceutical industries
The next decade promises to be an exciting time for science and innovation. Technological advancements are being made on a daily basis and many of these have the potential to directly impact our everyday lives. In fact, technology is changing at such a rate that it can often seem difficult to keep up.
As augmented reality (AR) technology continues to mature, more life science companies are expanding its use, enabling a new class of innovative content for field teams to bring treatments to light. Whether demonstrating a new therapy, showing how a new medical device works or providing details about a complex disease state, AR can improve customer engagement, education and brand differentiation.
The members of the launch class of 2017 wasted no time in passing more established competitors.
During the year following the launch of a new product, a good commercial operations team should accumulate an abundance of helpful sales-related data. Analyzed properly, that data can help executives make better decisions and improve the product’s chances for long-term success. The challenge is: Where to start? How can the commercial team use sales data to better target physicians and better direct the sales force?
A look at potential new developments important to health communications and marketing.
In the wake of W2O being invested in by private equity firm New Mountain Capital, Med Ad News had a conversation with W2O CEO and founder Jim Weiss about the origins of the company, what makes it stand out from the competition, and how he wants to expand the company’s services.
Chris Palmer was named CEO of the global healthcare advertising network CDM.
Whatever you might think you know about cancer, you’ll discover a huge knowledge gap when you receive a cancer diagnosis yourself. No matter how many oncology products you’ve helped launch, how much research you’ve read, how many physicians and patients you’ve spoken with, you’ll still be hit by the unknown and unexpected. That was my experience when I was diagnosed with breast cancer in May 2005.
AbelsonTaylor hired veteran marketing strategist Christopher Dimmock as senior VP of customer insights and engagement. AbelsonTaylor also named Lynnette Hunter, senior VP, account director, and Tristen George, senior VP, experience design, to the company’s 14-member group of shareholders.